BBS12 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-38939
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to amino acids: EFEASTYIQHHLQNATDSGSPSSYILNEYSKLNSRIFNSDISNKLEQIPRVYDVVTPKIEAWRRALDLVLLVLQTDSEIITGHGHTQINSQELTGFL
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for BBS12 Antibody
Immunohistochemistry: BBS12 Antibody [NBP2-38939]
Immunohistochemistry: BBS12 Antibody [NBP2-38939] - Staining of human kidney shows strong membranous positivity in cells in tubules.Applications for BBS12 Antibody
Application
Recommended Usage
Immunohistochemistry
1:20 - 1:50
Immunohistochemistry-Paraffin
1:20 - 1:50
Application Notes
For IHC-Paraffin, HIER pH 6 retrieval is recommended.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: BBS12
Alternate Names
Bardet-Biedl syndrome 12, chromosome 4 open reading frame 24, FLJ35630C4orf24Bardet-Biedl syndrome 12 protein, FLJ41559
Gene Symbol
BBS12
UniProt
Additional BBS12 Products
Product Documents for BBS12 Antibody
Product Specific Notices for BBS12 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...